Amyris Inc. (AMRS:US), the biotechnology company partially owned by Total SA (FP), received almost $11 million from France’s largest oil producer to continue researching the chemical compound farnesene.
The debt taken on by Emeryville, California-based Amyris came from convertible notes, Joel Velasco, a company spokesman, said today in an e-mail.
Total, Amyris’s largest shareholder, owned almost 21 percent of Amyris as of May 29, according to data (AMRS:US) compiled by Bloomberg.
Amyris deploys genetically modified microorganisms to convert plant sugars into fragrance oils or farnesene, a hydrocarbon used to make specialty chemicals or fuels.
To contact the reporter on this story: Justin Doom in New York at email@example.com
To contact the editors responsible for this story: Reed Landberg at firstname.lastname@example.org Robin Saponar